UNSPSC 51112034: Baricitinib

Baricitinib is a drug for the treatment of rheumatoid arthritis (RA) in adults whose disease was not well controlled using RA medications called tumor necrosis factor (TNF) antagonists. It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2.

UNSPSC 51112034 Baricitinib is a Commodity code that does not show relevant recent activity in state and local procurement. The recent solicitations tagged to this code do not reflect purchases of Baricitinib or other pharmaceuticals matching the code's nominal scope. Instead, the opportunities span unrelated categories including facility relocation notices, reverse trade shows, vendor forums, nursing and healthcare services, forensic drug standards, oxygen cylinder rental, and cooperative purchasing alliances for multi-source generic pharmaceuticals—none of which constitute direct procurement of this specific biopharmaceutical product.

The code appears inactive for targeted state and local buying. Baricitinib-specific procurement by states, counties, cities, school districts, or other state and local bodies does not surface in recent notices. Broader pharmaceutical purchasing does occur through cooperative vehicles like MMCAP (Minnesota Multistate Cooperative Purchasing Alliance) and through health departments procuring EMS supplies and forensic materials, but no issuing body has solicited Baricitinib explicitly. This code may see opportunistic use when health systems, correctional facilities, or state Medicaid programs refresh drug formularies, but no active solicitations targeting this product line are presently visible.